The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Tumor risks and genotypeâphenotypeâproteotype analysis in 358 patients with germline mutations in SDHB and SDHD
Open accessAbstract
Succinate dehydrogenase B (SDHB) and D (SDHD) subunit gene mutations predispose to adrenal and extraadrenal pheochromocytomas, head and neck paragangliomas (HNPGL), and other tumor types. We report tumor risks in 358 patients with SDHB (n=295) and SDHD (n=63) mutations. Risks of HNPGL and pheochromocytoma in SDHB mutation carriers were 29% and 52%, respectively, at age 60 years and 71% and 29%, respectively, in SDHD mutation carriers. Risks of malignant pheochromocytoma and renal tumors (14% at age 70 years) were higher in SDHB mutation carriers; 55 different mutations (including a novel recurrent exon 1 deletion) were identified. No clear genotype-phenotype correlations were detected for SDHB mutations. However, SDHD mutations predicted to result in loss of expression or a truncated or unstable protein were associated with a significantly increased risk of pheochromocytoma compared to missense mutations that were not predicted to impair protein stability (most such cases had the common p.Pro81Leu mutation). Analysis of the largest cohort of SDHB/D mutation carriers has enhanced estimates of penetrance and tumor risk and supports in silicon protein structure prediction analysis for functional assessment of mutations. The differing effect of the SDHD p.Pro81Leu on HNPGL and pheochromocytoma risks suggests differing mechanisms of tumorigenesis in SDH-associated HNPGL and pheochromocytoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“…2005; Pollard et al., 2006] and activation of hypoxiainducible factors (HIF) pathways with SDH inactivation has been linked to accumulation of succinate and resulting inhibition of prolyl hydroxylase enzymes that are necessary for proteosomal degradation of HIF-alpha subunits [Selak et al., 2005].”
BackgroundInfluentialMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Self-citationNeumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II
Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., & Rao, Z. (2005) · Cell · doi:10.1016/j.cell.2005.05.025 · Cited by 881
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
Self-citationStructure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“Interestingly, germline mutations in SDHA have not been associated with neoplasia but can cause an autosomal recessive juvenile encephalopathy [Bourgeron et al., 1995].”
BackgroundGenetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
Self-citationLee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.015 · Cited by 527
Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Amar, L., Baudin, E., Burnichon, N., Peyrard, S., Silvera, S., Bertherat, J., Bertagna, X., Schlumberger, M., Jeunemaitre, X., Gimenez-Roqueplo, A.-P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0709 · Cited by 450
Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
A.Crossey, P., M.Richards, F., Foster, K., reen, J. S., Prowse, A., Latlf, F., Lerman, M. I., Zbar, B., Atfara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.8.1303 · Cited by 382
Self-citationBurnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 378
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
Germline SDHB Mutations and Familial Renal Cell Carcinoma
Ricketts, C., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 342
Self-citationBaysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 339
Schiavi, F. (2005) · JAMA · doi:10.1001/jama.294.16.2057 · Cited by 329
Brouwers, F. M., Eisenhofer, G., Tao, J. J., Kant, J. A., Adams, K. T., Linehan, W. M., & Pacak, K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0423 · Cited by 316
Mannelli, M., Castellano, M., Schiavi, F., Filetti, S., Giacchè, M., Mori, L., Pignataro, V., Bernini, G., Giachè, V., Bacca, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2419 · Cited by 303
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 276
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Genotype-phenotype correlations in von Hippel-Lindau disease
Ong, K. R., Woodward, E. R., Killick, P., Lim, C., Macdonald, F., & Maher, E. R. (2007) · Human Mutation · doi:10.1002/humu.20385 · Cited by 250
Self-citationGermline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
Self-citationNi, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., Platzer, P., Orloff, M. S., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.011 · Cited by 222
Topham, C. M., Srinivasan, N., & Blundell, T. L. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.7 · Cited by 208
Self-citationAstrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., & Baysal, B. E. (2003) · Human Genetics · doi:10.1007/s00439-003-0969-6 · Cited by 187
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Self-citationBayley, J.-P., van Minderhout, I., Weiss, M. M., Jansen, J. C., Oomen, P. H., Menko, F. H., Pasini, B., Ferrando, B., Wong, N., Alpert, L. C., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-1 · Cited by 166
Taschner, P. E. M., Jansen, J. C., Baysal, B. E., Bosch, A., Rosenberg, E. H., Bröcker‐Vriends, A. H. J. T., van der Mey, A. G. L., van Ommen, G. B., Cornelisse, C. J., & Devilee, P. (2001) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.1144 · Cited by 165
Piruat, J. I., Pintado, C. O., Ortega‐Sáenz, P., Roche-Molina, M., & López‐Barneo, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10933-10940.2004 · Cited by 160
Pollard, P. J., El-Bahrawy, M. A., Poulsom, R., Elia, G., Killick, P., Kelly, G. P., Hunt, T., Jeffery, R. E., Seedhar, P., Barwell, J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0920 · Cited by 154
Self-citationZatyka, M., da Silva, N. F., Clifford, S. C., Morris, M. R., Wiesener, M. S., Eckardt, K., Houlston, R. S., Richards, F. M., Latif, F., & Maher, E. R. (2002) · PubMed · doi:10.25405/ncl.34582002 · Cited by 147
Self-citationYoung, A. L., Baysal, B. E., Deb, A., & Young, W. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020312 · Cited by 130
Astuti, D., Hart‐Holden, N., Latif, F., Lalloo, F. I., Black, G. C. M., Lim, C., Moran, A., Grossman, A. B., Hodgson, S. V., Freemont, A. J., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01914.x · Cited by 112
Self-citationBenn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206300 · Cited by 108
Szeto, S. S. W., Reinke, S. N., Sykes, B. D., & Lemire, B. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700601200 · Cited by 104
Webster, A. R., Richards, F. M., MacRonald, F. E., Moore, A. T., & Maher, E. R. (1998) · The American Journal of Human Genetics · doi:10.1086/302037 · Cited by 98
Self-citationGenetic screening for pheochromocytoma: should SDHC gene analysis be included?: Figure 1
Mannelli, M., Ercolino, T., Giaché, V., Simi, L., Cirami, C. L., & Parenti, G. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051045 · Cited by 94
Paraganglioma after Maternal Transmission of a Succinate Dehydrogenase Gene Mutation
Pigny, P., Vincent, A., Bauters, C. C., Bertrand, M., de Montpréville, V., Crepin, M., Porchet, N., & Caron, P. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1989 · Cited by 93
Chelliah, V., Chen, L., Blundell, T. L., & Lovell, S. C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.022 · Cited by 93
Self-citationMcWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0769 · Cited by 89
Clinical and molecular progress in hereditary paraganglioma: Figure 1
Baysal, B. E. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058560 · Cited by 86
Badenhop, R. F., Jansen, J. C., Fagan, P. A., Lord, R. S. A., Wang, Z. G., Foster, W. J., & Schofield, P. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.011551 · Cited by 86
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez–Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 85
Molecular characterisation of a common SDHB deletion in paraganglioma patients
Cascón, A., Landa, I., López-Jiménez, E. A., Díez-Hernández, A., Buchta, M., Montero‐Conde, C., Leskelä, S., Leandro-Garcia, L. J., Letón, R., Rodríguez‐Antona, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054965 · Cited by 82
Badenhop, R. F., Cherian, S. M., Lord, R. S. A., Baysal, B. E., Taschner, P. E. M., & Schofield, P. R. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1142 · Cited by 74
Worth, C. L., Bickerton, G. R., Schreyer, A. M., Forman, J., Cheng, T. M. K., Lee, S., Gong, S., Burke, D. F., & Blundell, T. L. (2007) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720007003120 · Cited by 70
Self-citationForman, J., Worth, C. L., Bickerton, G. R., Eisen, T. G., & Blundell, T. L. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22419 · Cited by 64
Self-citationHenderson, A., Douglas, F., Perros, P., Morgan, C., & Maher, E. R. (2009) · Familial Cancer · doi:10.1007/s10689-009-9234-z · Cited by 59
Self-citationLima, J. P., Feijão, T., da Silva, A. F., Pereira‐Castro, I., Fernandez-Ballester, G. J., Máximo, V., Herrero, A., Serrano, L. G., Sobrinho-Simões, M. A., & García‐Rostán, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0640 · Cited by 56
Smith, R. E., Lovell, S. C., Burke, D. F., Montalvão, R. W., & Blundell, T. L. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm073 · Cited by 48
Self-citationParaganglioma Syndrome: SDHB, SDHC, and SDHD Mutations in Head and Neck Paragangliomas
Schiavi, F., Savvoukidis, T., Trabalzini, F., Grego, F., Piazza, M., Amistà, P., Demattè, S., Piano, A. D., Cecchini, M. E., Erlic, Z., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.020 · Cited by 41
Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.
Braun, S., Riemann, K., Kupka, S., Leistenschneider, P., Sotlar, K., Schmid, H., & Blin, N. (2005) · PubMed · Cited by 38
Armstrong, R., Greenhalgh, K. L., Rattenberry, E., Judd, B., Shukla, R., Losty, P. D., & Maher, E. R. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060749 · Cited by 29
Self-citationPediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutations
Mora, J., Cascón, A., Robledo, M., & Català, A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20680 · Cited by 21
McDonnell, C. M., Benn, D. E., Marsh, D. J., Robinson, B. G., & Zacharin, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02122.x · Cited by 21
A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene
Drucker, A. M., & Houlden, R. L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0342 · Cited by 14
Lawrence, J., Maher, E. R., Sheaves, R., & Grossman, A. B. (2004) · HORMONES · doi:10.14310/horm.2002.11121 · Cited by 13
Self-citation
Cited by
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000
SDM--a server for predicting effects of mutations on protein stability and malfunction
Worth, C. L., Preissner, R., & Blundell, T. L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr363 · Cited by 565
Self-citationSuccinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
Metadata
- Authors
- Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., Atkinson, A. B., Douglas, F., Ball, S. G., Cook, J., Srirangalingam, U., Killick, P., Kirby, G., Aylwin, S., Woodward, E. R., Evans, D. G. R., Hodgson, S. V., Murday, V., Chew, S. L., Connell, J. M., Blundell, T. L., MacDonald, F., & Maher, E. R.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2010-01
- Volume
- 31
- Issue
- 1
- Pages
- 41-51
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2011400718
- Cited by
- 337
- References
- 63
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.